Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection

Por ALEEM, EIMAN, ELSHAYEB, AYMAN, ELHABACHI, NIHAL, MANSOUR, AMAL REFAAT, GOWILY, AHMED, HELA, ASMAA
Publicado em 2011